Is Biotest AG halal to invest in?

According to Musaffa's Shariah screening methodology, Biotest AG (BIO.DE) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Biotest AG a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Biotest AG using these criteria to determine its compliance status.

Can Muslims buy shares of Biotest AG?

Muslim investors may consider investing in Biotest AG if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Biotest AG classified as NOT HALAL?

Musaffa determines the Shariah status of Biotest AG by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Biotest AG updated?

The Shariah compliance status of Biotest AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Biotest AG become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Biotest AG?

You can check the latest Shariah compliance status of Biotest AG on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Biotest AG BIO.DE

€42.20

Last Updated: Jun 06, 12:00 AM·XETRA

BIO.DE Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 04, 2026

Report Source: 2025 1st Quarter Report

Analyst's Ratings for Biotest AG (BIO.DE)

Based on 7 analysts giving stock ratings to Biotest AG in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Biotest AG. Stock Analysis BIO.DE

Germany Health Care Small Cap Report: Q1, 2025

Biotest AG is a DE-based company operating in Biotechnology industry. The company is headquartered in Dreieich, Hessen and currently employs 2,495 full-time employees. Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. The company develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.

Key Statistics of Biotest AG (BIO.DE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€42.20€43.00

Today's Open

€42.20

Volume

175.00

P/E Ratio (TTM)

53.87

52 Week Range

€40.40€43.20

Market Cap

1.44B

Avg. Volume

198.87

Dividend Yield

Financial Metrics & Statements of Biotest AG (BIO.DE)

FAQ's for Biotest AG (BIO.DE)

According to Musaffa’s Shariah screening methodology, Biotest AG (BIO.DE) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.